Post by Vertical

Partnerships are built on trust, not just technology. Our CSO Jason Hill, shares his insights on a critical shift in the South Korean biotech and healthtech investment landscape during a media interview at Bio Korea 2026. 🔸 While South Korean companies in sectors like AI diagnostics are pushing global boundaries, many face challenges when entering Western markets. Jason points out that bridging this gap requires more than just clinical milestones. 🔸 For true success, cutting-edge technology is not enough on its own. Companies also need strong business development expertise and the ability to articulate their value as clearly and engagingly as possible. “You must be able to collaborate closely over short distances and communicate about the value you can co-create.” 💎 At the end of the day, data gets you a seat at the table, but trust and a compelling narrative are what actually close the deal. 💎 #Biotech #BusinessDevelopment #BioKorea2026